Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Lacuna

Founders Werner Engelhardt

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$14M
Portfolio companies 5
Rounds per year 0.20
Lead investments 2
Exits 1
Key employees 1
Stages of investment
Early Stage Venture

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
Summary

Lacuna appeared to be the VC, which was created in 1996. The main department of described VC is located in the Regensburg. The fund was located in Europe if to be more exact in Germany.

Among the most popular fund investment industries, there are Software, Medical. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight MerLion Pharma, Stokes Bio, Peak8 Partners.

The current fund was established by Werner Engelhardt.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2008. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. This Lacuna works on 9 percentage points less the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Lacuna, startups are often financed by Temasek Holdings, Novartis Venture Fund, JAFCO Asia. The meaningful sponsors for the fund in investment in the same round are Zu00fcrcher Kantonal Bank, Idinvest Partners, EDBI. In the next rounds fund is usually obtained by Tragara, Spartan Mobile, Sofinnova Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Lacuna:
Typical Co-investors
Lacuna is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Lacuna:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aulas AMiGAS Antioquia, Colombia, Medellín
AWDK Invest Capital Region of Denmark, Copenhagen, Denmark
Axcel Partners Maryland, Stevenson, United States
Gepic Energy Development China, Gansu, Lanzhou
Greenwood Gulch Ventures Colorado, Denver, United States
Melbourne Accelerator Program Australia, Melbourne, Victoria
Singapura Finance Central, Central Region, Singapore
Sino-Ocean Capital Beijing, Beijing, China
US Renewables California, Santa Monica, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Software
$5M22 Feb 2008 Boulder, Colorado, United States

Auris Medical

Health Care
Pharmaceutical
Therapeutics
$10M15 Feb 2008 Basel, Basel-City, Switzerland

Mocapay

E-Commerce
Enterprise Software
Finance
$3M12 Jul 2007 Denver, Colorado, United States

MerLion Pharma

Biotechnology
Pharmaceutical
$30M01 Mar 2007 Central

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Lacuna?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 14M
Rounds per year 0.20
Peak activity year 2008
Lead investments 2
Exits 1
Group Appearance index 0.60

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Software
$5M22 Feb 2008 Boulder, Colorado, United States

Auris Medical

Health Care
Pharmaceutical
Therapeutics
$10M15 Feb 2008 Basel, Basel-City, Switzerland

Mocapay

E-Commerce
Enterprise Software
Finance
$3M12 Jul 2007 Denver, Colorado, United States

MerLion Pharma

Biotechnology
Pharmaceutical
$30M01 Mar 2007 Central
Crunchbase icon

Content report

The following text will be sent to our editors: